NOVOPHARM MARKETING GENERIC RANITIDINE THROUGH AGREEMENT WITH GENPHARM; THREE-WEEK DELAY BRINGS GLAXO $100 MIL. IN ADDITIONAL ZANTAC SALES

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".